Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Kosmas C, Tsavaris N, Syrigos K, Koutras A, Tsakonas G, Makatsoris T, Mylonakis N, Karabelis A, Stathopoulos GP, Kalofonos HP. Kosmas C, et al. Among authors: stathopoulos gp. Cancer Chemother Pharmacol. 2007 Jan;59(1):51-9. doi: 10.1007/s00280-006-0242-5. Epub 2006 Apr 19. Cancer Chemother Pharmacol. 2007. PMID: 16622691 Clinical Trial.
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
Stathopoulos GP, Christodoulou Ch, Stathopoulos J, Skarlos D, Rigatos SK, Giannakakis T, Armenaki O, Antoniou D, Athanasiadis A, Giamboudakis P, Dimitroulis J, Georgatou N, Katis K. Stathopoulos GP, et al. Among authors: stathopoulos j. Cancer Chemother Pharmacol. 2006 Jun;57(6):796-800. doi: 10.1007/s00280-005-0085-5. Epub 2005 Sep 2. Cancer Chemother Pharmacol. 2006. PMID: 16142488 Clinical Trial.
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
Stathopoulos GP, Syrigos K, Aravantinos G, Polyzos A, Papakotoulas P, Fountzilas G, Potamianou A, Ziras N, Boukovinas J, Varthalitis J, Androulakis N, Kotsakis A, Samonis G, Georgoulias V. Stathopoulos GP, et al. Br J Cancer. 2006 Sep 4;95(5):587-92. doi: 10.1038/sj.bjc.6603301. Epub 2006 Aug 8. Br J Cancer. 2006. PMID: 16909140 Free PMC article. Clinical Trial.
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
Kotsakis A, Agelaki S, Vardakis N, Stathopoulos G, Vamvakas L, Kalykaki A, Kentepozidis N, Kontopodis E, Sfakiotaki G, Mavroudis D, Georgoulias V. Kotsakis A, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):415-22. doi: 10.1007/s00280-010-1508-5. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069335 Clinical Trial.
144 results